Literature DB >> 21539311

Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra.

Gerald S Baron1, Andrew G Hughson, Gregory J Raymond, Danielle K Offerdahl, Kelly A Barton, Lynne D Raymond, David W Dorward, Byron Caughey.   

Abstract

Mammalian prion diseases involve conversion of normal prion protein, PrP(C), to a pathological aggregated state (PrP(res)). The three-dimensional structure of PrP(res) is not known, but infrared (IR) spectroscopy has indicated high, strain-dependent β-sheet content. PrP(res) molecules usually contain a glycophosphatidylinositol (GPI) anchor and large Asn-linked glycans, which can also vary with strain. Using IR spectroscopy, we tested the conformational effects of these post-translational modifications by comparing wild-type PrP(res) with GPI- and glycan-deficient PrP(res) produced in GPI-anchorless PrP transgenic mice. These analyses required the development of substantially improved purification protocols. Spectra of both types of PrP(res) revealed conformational differences between the 22L, ME7, and Chandler (RML) murine scrapie strains, most notably in bands attributed to β-sheets. These PrP(res) spectra were also distinct from those of the hamster 263K scrapie strain. Spectra of wild-type and anchorless 22L PrP(res) were nearly indistinguishable. With ME7 PrP(res), modest differences between the wild-type and anchorless spectra were detected, notably an ∼2 cm(-1) shift in an apparent β-sheet band. Collectively, the data provide evidence that the glycans and anchor do not grossly affect the strain-specific secondary structures of PrP(res), at least relative to the differences observed between strains, but can subtly affect turns and certain β-sheet components. Recently reported H-D exchange analyses of anchorless PrP(res) preparations strongly suggested the presence of strain-dependent, solvent-inaccessible β-core structures throughout most of the C-terminal half of PrP(res) molecules, with no remaining α-helix. Our IR data provide evidence that similar core structures also comprise wild-type PrP(res).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21539311      PMCID: PMC3101284          DOI: 10.1021/bi2003907

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  57 in total

1.  Eight prion strains have PrP(Sc) molecules with different conformations.

Authors:  J Safar; H Wille; V Itri; D Groth; H Serban; M Torchia; F E Cohen; S B Prusiner
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

2.  Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.

Authors:  P Parchi; R Castellani; S Capellari; B Ghetti; K Young; S G Chen; M Farlow; D W Dickson; A A Sima; J Q Trojanowski; R B Petersen; P Gambetti
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

3.  Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform.

Authors:  N Naslavsky; R Stein; A Yanai; G Friedlander; A Taraboulos
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

4.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

Authors:  J Collinge; K C Sidle; J Meads; J Ironside; A F Hill
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

5.  Biogenesis and transmembrane orientation of the cellular isoform of the scrapie prion protein [published errratum appears in Mol Cell Biol 1987 May;7(5):2035].

Authors:  B Hay; R A Barry; I Lieberburg; S B Prusiner; V R Lingappa
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

6.  Cell-free formation of protease-resistant prion protein.

Authors:  D A Kocisko; J H Come; S A Priola; B Chesebro; G J Raymond; P T Lansbury; B Caughey
Journal:  Nature       Date:  1994-08-11       Impact factor: 49.962

7.  Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy.

Authors:  R A Bessen; R F Marsh
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231).

Authors:  R Riek; S Hornemann; G Wider; R Glockshuber; K Wüthrich
Journal:  FEBS Lett       Date:  1997-08-18       Impact factor: 4.124

9.  NMR structure of the mouse prion protein domain PrP(121-231).

Authors:  R Riek; S Hornemann; G Wider; M Billeter; R Glockshuber; K Wüthrich
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

10.  Strain-dependent differences in beta-sheet conformations of abnormal prion protein.

Authors:  B Caughey; G J Raymond; R A Bessen
Journal:  J Biol Chem       Date:  1998-11-27       Impact factor: 5.157

View more
  51 in total

Review 1.  Prions on the move.

Authors:  Charles Weissmann; Jiali Li; Sukhvir P Mahal; Shawn Browning
Journal:  EMBO Rep       Date:  2011-10-28       Impact factor: 8.807

Review 2.  Prions and the potential transmissibility of protein misfolding diseases.

Authors:  Allison Kraus; Bradley R Groveman; Byron Caughey
Journal:  Annu Rev Microbiol       Date:  2013-06-28       Impact factor: 15.500

3.  4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration.

Authors:  Eri Saijo; Michael A Metrick; Shunsuke Koga; Piero Parchi; Irene Litvan; Salvatore Spina; Adam Boxer; Julio C Rojas; Douglas Galasko; Allison Kraus; Marcello Rossi; Kathy Newell; Gianluigi Zanusso; Lea T Grinberg; William W Seeley; Bernardino Ghetti; Dennis W Dickson; Byron Caughey
Journal:  Acta Neuropathol       Date:  2019-10-16       Impact factor: 17.088

4.  Prion protein glycans reduce intracerebral fibril formation and spongiosis in prion disease.

Authors:  Alejandro M Sevillano; Patricia Aguilar-Calvo; Timothy D Kurt; Jessica A Lawrence; Katrin Soldau; Thu H Nam; Taylor Schumann; Donald P Pizzo; Sofie Nyström; Biswa Choudhury; Hermann Altmeppen; Jeffrey D Esko; Markus Glatzel; K Peter R Nilsson; Christina J Sigurdson
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

5.  Dual conformation of H2H3 domain of prion protein in mammalian cells.

Authors:  Zhou Xu; Stéphanie Prigent; Jean-Philippe Deslys; Human Rezaei
Journal:  J Biol Chem       Date:  2011-09-12       Impact factor: 5.157

6.  A stretch of residues within the protease-resistant core is not necessary for prion structure and infectivity.

Authors:  Carola Munoz-Montesino; Christina Sizun; Mohammed Moudjou; Laetitia Herzog; Fabienne Reine; Angelique Igel-Egalon; Clément Barbereau; Jérôme Chapuis; Danica Ciric; Hubert Laude; Vincent Béringue; Human Rezaei; Michel Dron
Journal:  Prion       Date:  2017-02-08       Impact factor: 3.931

7.  Increased infectivity of anchorless mouse scrapie prions in transgenic mice overexpressing human prion protein.

Authors:  Brent Race; Katie Phillips; Kimberly Meade-White; James Striebel; Bruce Chesebro
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

8.  Identification and removal of proteins that co-purify with infectious prion protein improves the analysis of its secondary structure.

Authors:  Roger A Moore; Andrew G Timmes; Phillip A Wilmarth; David Safronetz; Suzette A Priola
Journal:  Proteomics       Date:  2011-09-07       Impact factor: 3.984

Review 9.  High-resolution structure of infectious prion protein: the final frontier.

Authors:  Rodrigo Diaz-Espinoza; Claudio Soto
Journal:  Nat Struct Mol Biol       Date:  2012-04-04       Impact factor: 15.369

10.  Parallel in-register intermolecular β-sheet architectures for prion-seeded prion protein (PrP) amyloids.

Authors:  Bradley R Groveman; Michael A Dolan; Lara M Taubner; Allison Kraus; Reed B Wickner; Byron Caughey
Journal:  J Biol Chem       Date:  2014-07-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.